| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/27/2005 | US20050019921 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 01/27/2005 | US20050019918 Nucleotide sequences for controlling mitogen activated kinase expression for use in the treatment of cell proliferative disorders; antisense oligonucleotides |
| 01/27/2005 | US20050019916 oligonucleotides used for detection and analyzing analytes in solution |
| 01/27/2005 | US20050019915 Oligonucleotides for use in controlling expression of gene coding polypeptide associated with catalyzing the dismutation of superoxide to hydrogen peroxide; antiproliferative agents; antitumor agents; gene expression inhibition |
| 01/27/2005 | US20050019913 Methods for cultivating cells and propagating viruses |
| 01/27/2005 | US20050019908 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 01/27/2005 | US20050019896 Ourifying supercoiled vector DNA from cell lysate via crystallized calcium silicate adsorption; DNA extraction |
| 01/27/2005 | US20050019893 Sequences for detection and identification of methicillin-resistant staphyloccocus |
| 01/27/2005 | US20050019891 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019888 Proteases from gram positive organisms |
| 01/27/2005 | US20050019887 Mutant nucleic acid; applying to textiles; mixture with metal compound |
| 01/27/2005 | US20050019886 Generating/designing hydrolase mutants for use in detergents, papermaking and textile treatment |
| 01/27/2005 | US20050019885 Human protein for use in identifying modulator for diagnosis, drug screening, clinical trial monitoring and treatment of metabolic disorders; cosmetics; nutriceutical |
| 01/27/2005 | US20050019882 Using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates; terpenoid biosynthesis |
| 01/27/2005 | US20050019879 Transgenic yeast comprising nucleotide sequences coding L-galactose dehydrogenase (LGDH) for use as enhanced source for generating vitamin c; bioreactor |
| 01/27/2005 | US20050019877 Genes coding for metabolic pathway proteins |
| 01/27/2005 | US20050019875 Sample processing device and method |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019869 Chimeric neuropeptide Y receptors |
| 01/27/2005 | US20050019867 Alpha 1,4-galactosyl transferase and DNA encoding thereof |
| 01/27/2005 | US20050019866 Nucleotide sequences coding membrane protein for use in diagnosis, detection, prevention and/or treatment of cell proliferative disorders |
| 01/27/2005 | US20050019864 Novel peptide-forming enzyme gene |
| 01/27/2005 | US20050019861 genetic engineered hydrolase enzymes used for prophylaxis of Gaucher's disease |
| 01/27/2005 | US20050019858 Novel human cytokine/steroid receptor protein |
| 01/27/2005 | US20050019857 Expression vector comprising outer membrane protein F (OMPF) regulatory and gene for use as tools in efficient heterologous gene expression; bioreactors |
| 01/27/2005 | US20050019854 Analyzing insulin response; solid phase synthesis; for treatment of prediabetes, hyperinsulinemia, and type II diabetes; kits |
| 01/27/2005 | US20050019852 transforming the host cells to express a heterologous, codon-optimized gene encoding a carotene desaturase for the in vivo bioconversion of beta-carotene and/or gamma-carotene into isorenieratene, chlorobactene and/or beta-isorenieratene; Escherichia coli carotene desaturase gene |
| 01/27/2005 | US20050019851 Use of VLCFAE for identifying herbicidally active compounds |
| 01/27/2005 | US20050019840 Non-endogenous, constitutively activated known G protein-coupled receptors |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019833 Proteins capable of binding to environmental hormones and process for producing the same |
| 01/27/2005 | US20050019832 IGF-1 receptor interacting proteins |
| 01/27/2005 | US20050019829 Generating and identifying polypeptide stability, folding and/or solubility mutants comprising; mutagenizing gene sequences, expressing in hosst cell, determine protein structure |
| 01/27/2005 | US20050019827 Method for unspecific enrichment of bacterial cells |
| 01/27/2005 | US20050019826 Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019822 Using presence of short tandem repeat sequence in promoter region of cholecystokinin gene as a diagnostic indicator of panic associated psychological/psychiatric disorders; anxiolytic agents |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019819 DNA isolation method |
| 01/27/2005 | US20050019817 Producing oligonucleotides extended by a single nucleotide base; comprising preparing single stranded nucleotide mixture, incubate with terminal transferase and labeled chain terminating agents, recovvering reaction product; generating oligonucleotide standards |
| 01/27/2005 | US20050019816 Process for producing optically active-4-halo-3-hydroxybutanoate |
| 01/27/2005 | US20050019814 Pressure-enhanced extraction and purification |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019811 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019808 Compositions and methods for regulating mRNA transcription and translation |
| 01/27/2005 | US20050019797 Using gene expression patterns, generated after exposure of cell to mediator protein, to elucidate gene components of preferential biological pathway; reconstructing networks of relationships between genes |
| 01/27/2005 | US20050019791 Amidation; lamination; solid phase synthesis; detecting hybridization; genotyping |
| 01/27/2005 | US20050019790 Fixation of nucleotide derivatives to solid carrier |
| 01/27/2005 | US20050019789 Thermostable DNA polymerase from anaerocellum thermophilum |
| 01/27/2005 | US20050019783 Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression |
| 01/27/2005 | US20050019780 Transforming cells with vector comprising nucleotide sequences coding membrane protein for use in identifying modulators for treatment of metabolic disorders; transmembrane traps; immunodiagnostics |
| 01/27/2005 | US20050019775 Separating method and an apparatus performing such a method |
| 01/27/2005 | US20050019773 Method for producing and identifying soluble protein domains |
| 01/27/2005 | US20050019772 Identifying periodontitis- or caries-associated bacterium using species specific probes; diagnosing periodontal disease |
| 01/27/2005 | US20050019770 Macroporous gel, its preparing and its use |
| 01/27/2005 | US20050019769 Obtain cells, lyse, separate cell components, resuspended in saline, subjet to enzymatic treatment, precipitate DNA, resuspend in low salt solution |
| 01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 01/27/2005 | US20050019767 Nucleic acid compositions conferring disease resistance |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019761 nucleobases are cytosine groups or mimetics; modified with polyethyleneglycol or a tocopheryl group; useful in inhibiting proliferation of pancreatic tumors |
| 01/27/2005 | US20050019752 Novel chimeric rev, tat, and nef antigens |
| 01/27/2005 | US20050019751 Contacting human scavenger receptor class B type I with polypeptide and measuring ability of test compound to inhibit binding; used in treatment and prophylaxis |
| 01/27/2005 | US20050019750 Method and device for isolating rna samples |
| 01/27/2005 | US20050019749 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 and process for preparation thereof |
| 01/27/2005 | US20050019347 Dna sequences and coding for hepatitis virus antigen |
| 01/27/2005 | US20050019346 Nucleic acids and regulatory sequences; gene expression; antitumor agents |
| 01/27/2005 | US20050019344 Antigens; vaccines; isolated peptide |
| 01/27/2005 | US20050019343 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 01/27/2005 | US20050019341 Gene that codes tumor antigen is detected by cytotoxic lymphocyte; isolated from Dna libraries |
| 01/27/2005 | US20050019335 Attenuated mutant Salmonella bacteria containing deactivated gene used as vaccine |
| 01/27/2005 | US20050019334 Interleukin antibody or fusion protein; comprising active material and FC domain; Escherichia coli cells |
| 01/27/2005 | US20050019330 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta |
| 01/27/2005 | US20050019324 Peptides and antibodies to muc 1 proteins |
| 01/27/2005 | US20050019320 Controlling food intake; controlling gene expression of G protein; polypeptide |
| 01/27/2005 | US20050019307 Therapy gene against mammary gland cancer; transcription control ; Dna |
| 01/27/2005 | US20050019304 Novel human mage-like protein |
| 01/27/2005 | US20050019297 Protein derived composition for skin care using spider silk protein or an analog with adjuvants |
| 01/27/2005 | US20050019261 Using serine protease inhibitor; contacting brain tissue; analyzing in variations in protease gene expression |
| 01/27/2005 | DE10331171A1 Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung Neutral protease (NP) and product using neutral protease for tissue dissociation as well as methods for its preparation |
| 01/27/2005 | DE10328067A1 Isoliertes Photoprotein Bolinopsin, sowie dessen Verwendung The isolated photoprotein Bolinopsin, and its use |
| 01/27/2005 | DE10106370B4 Oligonukleotidsonden zur Detektion von parodontopathogenen Bakterien mittels in situ-Hybridisierung Oligonucleotide probes for the detection of periodontal bacteria by means of in situ hybridization |
| 01/27/2005 | CA2805464A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2804901A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2537896A1 East coast fever vaccine based on ctl-specific schizont antigens |
| 01/27/2005 | CA2536376A1 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | CA2532783A1 Polypeptide having an improved cytosine deaminase activity |
| 01/27/2005 | CA2532781A1 The anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/27/2005 | CA2532630A1 Use of lymphocytes transformed with .alpha.-2-heremans-schmid glycoprotein (ahsg) to treat tgf-.beta.-mediated cancer |
| 01/27/2005 | CA2532352A1 Methods and pharmaceutical compositions for healing wounds |
| 01/27/2005 | CA2532323A1 Antibodies to cd44 vra and methods of use |
| 01/27/2005 | CA2532228A1 Lipid encapsulated interfering rna |
| 01/27/2005 | CA2532186A1 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | CA2532164A1 Subunit vaccine against respiratory syncytial virus infection |
| 01/27/2005 | CA2531709A1 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | CA2531698A1 Method for assaying protein-protein interaction |
| 01/27/2005 | CA2531571A1 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 01/27/2005 | CA2531069A1 Inhibition of syk kinase expression |
| 01/27/2005 | CA2530810A1 Genome mapping of functional dna elements and cellular proteins |
| 01/27/2005 | CA2530809A1 Novel phytase and gene |